由Ilaprazole的CYP450异型介导的计算药物相互作用预测与克洛皮多格雷尔联合使用
Priyadharshini Ananthathandavan1, Damodharan Narayanasamy2
1Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science & Technology, Kattankulathur-603203, Chengalpattu, Tamilnadu, India.
Future science OA
|May 31, 2024
概括
伊拉普拉不影响克洛皮多格雷尔的疗效,尽管药理动力学变化. 研究表明CYP2C19抑制的可能性很低,这表明这些药物之间的药物相互作用风险很小.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物相互作用 药物相互作用
- 临床药房 临床药房
背景情况:
- 克洛皮多格雷尔的疗效可能会受到药物相互作用 (DDI) 的影响.
- 质子抑制剂 (PPI) 是常用的,并且可以与克洛皮多格雷尔相互作用.
- 伊拉普拉的药理动力学可变性需要评估其相互作用潜力.
研究的目的:
- 预测和评估伊拉普拉和克洛皮多格雷尔之间的潜在药物相互作用.
- 评估伊拉普拉和潘托普拉抑制CYP2C19的可能性.
主要方法:
- 使用Way2Drug软件进行药物相互作用 (DDI) 预测.
- 计算涉及CYP450异酶的相互作用的概率 (ΔP).
- 专注于CYP2C19的相互作用潜力.
主要成果:
- 对CYP2C19的阳性ΔP值 (0.955) 表明它参与了伊拉普拉-克洛皮多格雷尔相互作用.
- 伊拉普拉和潘托普拉表明CYP2C19抑制的可能性很低.
结论:
- 伊拉普拉的药理动力学变异性似乎不会影响克洛皮多格雷尔的疗效.
- 与其他PPI相比,伊拉普拉和潘托普拉具有较低的CYP2C19抑制潜力.
- 建议进行进一步的体内和体外研究,以充分评估伊拉普拉-克洛皮多格雷尔相互作用.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
122
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
122
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Factors Affecting Protein-Drug Binding: Drug Interactions
133
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
133
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Drug Metabolism: Phase I Reactions
3.2K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.2K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
129
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
129


